Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression.
Sign Up to like & getrecommendations! Published in 2020 at "Cellular and molecular biology"
DOI: 10.14715/cmb/2019.66.1.8
Abstract: The purpose of this study was to investigate the effect of liposomal clodronate combined with Cisplatin or Sorafenib on the FOXQ1 expression and biological function of hepatocellular carcinoma cell lines. The expression of FOXQ1 was… read more here.
Keywords: liposomal clodronate; cisplatin sorafenib; expression; cell ... See more keywords
Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10081901
Abstract: Medullary thyroid carcinoma (MTC) is a well-known neuroendocrine carcinoma, derived from C cells of the thyroid gland. Additionally, MTC is an uncommon aggressive carcinoma that metastasizes to lymph nodes, bones, lungs and liver. For MTC,… read more here.
Keywords: thyroid carcinoma; cisplatin sorafenib; patient derived; medullary thyroid ... See more keywords